THE LONG–TERM OUTCOME OF S.M.A.R.T. VERSUS LUMINEXX NITINOL STENT IMPLAMTATION FOR AORTO–ILIAC ARTERY DISEASE

THE LONG–TERM OUTCOME OF S.M.A.R.T. VERSUS LUMINEXX NITINOL STENT IMPLAMTATION FOR AORTO–ILIAC ARTERY DISEASE

The primary endpoint was primary patency, while the secondary endpoints were primary assisted patency, secondary patency and major adverse limb events (MALE) that include all-cause death, myocardial infarction, stroke, major amputation and re-intervention.

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of the American College of Cardiology 2013-03, Vol.61 (10), p.E2082-E2082
Hauptverfasser: Shintani, Yoshiaki, Soga, Yoshimitsu, Iida, Osamu, Kawasaki, Daizo, Suzuki, Kenji, Hirano, Keisuke, Tazaki, Junichi, Miyashita, Yusuke, Kawasaki, Tomohiro
Format: Artikel
Sprache:eng
Schlagworte:
Cardiology
Cardiovascular
Heart attacks
Internal Medicine
Medical research
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The primary endpoint was primary patency, while the secondary endpoints were primary assisted patency, secondary patency and major adverse limb events (MALE) that include all-cause death, myocardial infarction, stroke, major amputation and re-intervention.
ISSN:0735-1097
1558-3597
DOI:10.1016/S0735-1097(13)62082-3